AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitatru M Tablet 50mg/500mg

Prescription Icon
Prescription Required

Marketer

Truecure Healthcare Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitatru M Tablet 50mg/500mg

Combiflex DM 50mg/500mg tablets contain a dual-action formula managing elevated blood glucose in type 2 diabetes patients. This helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Combiflex DM 50mg/500mg may be used independently or alongside other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily use at the same time maximizes effectiveness; discontinuation requires physician approval. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a possibility when combined with insulin or sulfonylureas; learn its symptoms and management. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or lactating individuals need medical consultation. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitatru M Tablet 50mg/500mg

No information provided. Please provide the text you wish me to rephrase.

Uses of Sitatru M Tablet 50mg/500mg

Managing type 2 diabetes

Major Benefits of Sitatru M Tablet 50mg/500mg:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitatru M 50mg/500mg tablets should be administered with a meal.

Common Side effects of Sitatru M Tablet 50mg/500mg:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitatru M Tablet 50mg/500mg:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitatru M 50mg/500mg tablets. Ingest the tablets whole; avoid crushing, chewing, or breaking them. Administer this medication with food.

How Sitatru M Tablet 50mg/500mg works:

The combination tablet Sitatru M (50mg/500mg) unites sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin effectiveness, and diminishes hepatic glucose output. Metformin, a biguanide, acts by reducing liver glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitatru M Tablet 50mg/500mg and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitatru M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitatru M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitatru M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitatru M 50mg/500mg tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitatru M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitatru M Tablet 50mg/500mg :

Should you forget a Sitatru M Tablet 50mg/500mg dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitatru M Tablet 50mg/500mg

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitatru M Tablet 50mg/500mg

Sitatru M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitatru M Tablet 50mg/500mg can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitatru M Tablet 50mg/500mg may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitatru M Tablet 50mg/500mg is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitatru M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication safely and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50mg/500mg can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitatru M Tablet 50mg/500mg combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitatru M Tablet 50mg/500mg may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients allergic to Sitatru M Tablet 50mg/500mg components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Sitatru M Tablet 50mg/500mg is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitatru M Tablet 50mg/500mg can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitatru M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitatru M Tablet 50mg/500mg may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Sitatru M Tablet 50mg/500mg components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitatru M Tablet 50mg/500mg is unsafe due to the increased risk of lactic acidosis.
Sitatru M Tablet 50mg/500mg can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitatru M and seek immediate medical attention.
Prolonged use of Sitatru M Tablet 50mg/500mg can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Sitatru M Tablet 50mg/500...
269